Large Genetic Study of Mole Count Adds 24 Regions Linked to Melanoma Risk

Australian researchers at QIMR Berghofer have completed a large-scale genome-wide association analysis focused on a seemingly everyday trait that is closely tied to skin cancer risk: how many moles a person has on their body. According to source reports, the study included data from more than 85,000 people of European ancestry and identified 24 genetic regions that had not previously been confirmed as being associated with mole count.

A higher mole count has long been regarded as one of the important risk indicators for melanoma. Melanoma is a potentially aggressive form of skin cancer, and some cases develop from existing moles; both moles and melanoma originate from melanocytes, the cells responsible for producing the pigment that affects skin color.

The importance of this study lies not only in expanding the genetic map associated with being prone to developing moles, but also in connecting these genetic signals to biological pathways that may be involved in cancer development. The source summary noted that the newly discovered regions involve immune responses and control of cell growth; if these systems become imbalanced, abnormal cells may be more likely to proliferate or evade immune surveillance.

However, this type of study mainly shows association and cannot, on its own, prove that a particular genetic change necessarily causes melanoma. Mole count and skin cancer risk are also jointly influenced by factors such as ultraviolet exposure, skin color, family history, and living environment, so genetic signals should be understood as one part of risk biology rather than a complete answer.

The study also has clear limitations. Participants were mainly of European ancestry, and whether the results can be directly applied to Asian, African, Indigenous, or mixed-ancestry populations still requires more data for confirmation. Differences in genetic background, skin type, and patterns of sun exposure across populations may all affect the accuracy of risk models.

In terms of clinical application, these findings are more likely in the short term to help scientists understand how melanoma forms, rather than immediately changing screening or treatment approaches for the general public. In the future, if more population data, functional experiments, and long-term follow-up can be combined, the relevant genetic regions may further become clues for risk stratification, prevention strategies, or research into new therapies.

For general readers, this study is another reminder that moles are not merely surface features of the skin, but may also reflect deeper differences in genetics and cell biology. But before scientific evidence is translated into medical recommendations, assessments of melanoma risk still need to rely on a complete medical history, skin examination, and professional medical evaluation.